Rachel Andrews

Q: What is Rachel Andrews email address?

Email Rachel Andrews at andrews.rachel@gene.com. This email is the most updated Rachel Andrews email found in 2026.

Q: How to contact Rachel Andrews?

To contact Rachel Andrews send an email to andrews.rachel@gene.com.

Principal Scientist-Pathologist, Translational Safety at Genentech | South San Francisco, California, United States

About Rachel Andrews

Rachel Andrews is a distinguished Principal Scientist-Pathologist in Safety Assessment at Genentech, where she leverages her expertise as a board-certified veterinary toxicologic pathologist to drive innovation in ocular therapeutics. With a keen focus on preclinical safety studies, Rachel plays a pivotal role in the design and execution of IND-enabling toxicology packages, ensuring that new treatments are both effective and safe for patients. As the Ocular Therapeutic Area Lead, she provides critical oversight and strategic guidance on the preclinical considerations for therapeutics targeting vision and ophthalmology, an area that is rapidly evolving and holds immense potential for improving patient outcomes.

Throughout her tenure at Genentech, Rachel has been an integral member of 15 project teams, where her contributions have spanned a variety of ocular diseases. Her expertise in veterinary pathology, combined with her proficiency in molecular biology techniques such as PCR and immunohistochemistry, enables her to conduct thorough assessments of animal models and interpret complex data sets. Rachel's commitment to advancing the field is evident in her meticulous approach to research and her ability to collaborate effectively with cross-functional teams.

Her passion for cutting-edge science is matched by her dedication to mentoring the next generation of scientists, fostering an environment of learning and innovation. As she continues to navigate the challenges of safety assessment in the rapidly advancing field of ophthalmology, Rachel remains focused on delivering transformative therapies that can significantly enhance the quality of life for patients suffering from vision-related ailments.

Rachel Andrews Work